Atlas Capital Advisors LLC Takeda Pharmaceutical CO LTD Transaction History

Atlas Capital Advisors LLC

  • $770 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
SELL
$13.36 - $15.43 $17,234 - $19,904
-1,290 Reduced 63.55%
740 $10.6 Million
Q3 2023

Nov 14, 2023
SELL
$15.03 - $16.32 $33,997 - $36,915
-2,262 Reduced 52.7%
2,030 $31.4 Million
Q2 2023

Aug 15, 2023
BUY
$15.57 - $17.11 $24,413 - $26,828
1,568 Added 57.56%
4,292 $67.4 Million
Q1 2023

May 16, 2023
BUY
$15.28 - $16.48 $41,622 - $44,891
2,724 New
2,724 $44.9 Million

Others Institutions Holding TAK

# of Institutions
320
Shares Held
70.4M
Call Options Held
939K
Put Options Held
233K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email